Prediction of allergic reaction risk of Shenmai injection based on real-world evidence coupled with UPLC-Q-TOF-MS

Biomed Chromatogr. 2022 Feb;36(2):e5255. doi: 10.1002/bmc.5255. Epub 2021 Oct 28.

Abstract

The allergic reaction (AR) of Chinese herbal injection (CHI) has become one of the most noticeable focuses of public health in China. However, it still remains a considerable controversy as to whether low-molecular-weight components in CHI have potential sensitization. In this study, the relationship between AR and low-molecular-weight component profile of Shenmai injection was explored by an interdisciplinary technology integrating real-world evidence and ultra-performance liquid chromatography-quadrupole time-of-flight mass spectroscopy (UPLC-Q-TOF-MS). The AR information of hospitalized patients was obtained by comprehensively analyzing real-world evidence from January 2015 to June 2019 at two Chinese hospitals. The UPLC-Q-TOF-MS was exploited to systematically investigate the low-molecular-weight component profile with 50-1500 m/z mass range, and 3725 MS1 peaks were detected. The optimized partial least squares discriminant analysis model was established to map the influence of low-molecular-weight components on AR. The results of this study showed that high levels of organic acids administered intravenously might be a potential risk factor for inducing AR. By using this method, Shenmai injection with high AR risk could be recognized precisely with 100% accuracy before clinical use.

Keywords: Shenmai injection; UPLC-Q-TOF-MS; allergic reaction; organic acid; real-world evidence.

MeSH terms

  • Adult
  • Chromatography, High Pressure Liquid / methods*
  • Discriminant Analysis
  • Drug Combinations
  • Drugs, Chinese Herbal* / adverse effects
  • Drugs, Chinese Herbal* / analysis
  • Drugs, Chinese Herbal* / chemistry
  • Hospitalization
  • Humans
  • Hypersensitivity / epidemiology*
  • Hypersensitivity / prevention & control
  • Least-Squares Analysis
  • Mass Spectrometry / methods*
  • Models, Statistical*
  • Reproducibility of Results
  • Risk Assessment

Substances

  • Drug Combinations
  • Drugs, Chinese Herbal
  • fructus schizandrae, radix ginseng, radix ophiopogonis drug combination